rs2306942

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000426.4(LAMA2):​c.3412G>A​(p.Val1138Met) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0581 in 1,612,986 control chromosomes in the GnomAD database, including 3,884 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1138V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.091 ( 933 hom., cov: 32)
Exomes 𝑓: 0.055 ( 2951 hom. )

Consequence

LAMA2
NM_000426.4 missense, splice_region

Scores

3
14
Splicing: ADA: 0.08566
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.15

Publications

31 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024026632).
BP6
Variant 6-129314655-G-A is Benign according to our data. Variant chr6-129314655-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.185 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA2NM_000426.4 linkc.3412G>A p.Val1138Met missense_variant, splice_region_variant Exon 24 of 65 ENST00000421865.3 NP_000417.3
LAMA2NM_001079823.2 linkc.3412G>A p.Val1138Met missense_variant, splice_region_variant Exon 24 of 64 NP_001073291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA2ENST00000421865.3 linkc.3412G>A p.Val1138Met missense_variant, splice_region_variant Exon 24 of 65 5 NM_000426.4 ENSP00000400365.2 P24043
LAMA2ENST00000618192.5 linkc.3676G>A p.Val1226Met missense_variant, splice_region_variant Exon 25 of 66 5 ENSP00000480802.2 A0A087WX80
LAMA2ENST00000617695.5 linkc.3412G>A p.Val1138Met missense_variant, splice_region_variant Exon 24 of 64 5 ENSP00000481744.2 A0A087WYF1

Frequencies

GnomAD3 genomes
AF:
0.0905
AC:
13757
AN:
151978
Hom.:
929
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.188
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.0627
Gnomad ASJ
AF:
0.0519
Gnomad EAS
AF:
0.138
Gnomad SAS
AF:
0.103
Gnomad FIN
AF:
0.0293
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0439
Gnomad OTH
AF:
0.0872
GnomAD2 exomes
AF:
0.0651
AC:
16343
AN:
251076
AF XY:
0.0638
show subpopulations
Gnomad AFR exome
AF:
0.191
Gnomad AMR exome
AF:
0.0485
Gnomad ASJ exome
AF:
0.0515
Gnomad EAS exome
AF:
0.147
Gnomad FIN exome
AF:
0.0299
Gnomad NFE exome
AF:
0.0425
Gnomad OTH exome
AF:
0.0608
GnomAD4 exome
AF:
0.0547
AC:
79906
AN:
1460890
Hom.:
2951
Cov.:
32
AF XY:
0.0552
AC XY:
40139
AN XY:
726772
show subpopulations
African (AFR)
AF:
0.191
AC:
6376
AN:
33460
American (AMR)
AF:
0.0479
AC:
2143
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0521
AC:
1362
AN:
26122
East Asian (EAS)
AF:
0.150
AC:
5968
AN:
39684
South Asian (SAS)
AF:
0.0836
AC:
7207
AN:
86160
European-Finnish (FIN)
AF:
0.0273
AC:
1457
AN:
53342
Middle Eastern (MID)
AF:
0.0826
AC:
444
AN:
5376
European-Non Finnish (NFE)
AF:
0.0460
AC:
51116
AN:
1111720
Other (OTH)
AF:
0.0636
AC:
3833
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
3739
7478
11216
14955
18694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2158
4316
6474
8632
10790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0907
AC:
13794
AN:
152096
Hom.:
933
Cov.:
32
AF XY:
0.0898
AC XY:
6680
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.189
AC:
7811
AN:
41430
American (AMR)
AF:
0.0626
AC:
957
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0519
AC:
180
AN:
3468
East Asian (EAS)
AF:
0.138
AC:
712
AN:
5162
South Asian (SAS)
AF:
0.103
AC:
496
AN:
4814
European-Finnish (FIN)
AF:
0.0293
AC:
311
AN:
10612
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.0439
AC:
2985
AN:
68010
Other (OTH)
AF:
0.0863
AC:
182
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
561
1123
1684
2246
2807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0588
Hom.:
2062
Bravo
AF:
0.0970
TwinsUK
AF:
0.0450
AC:
167
ALSPAC
AF:
0.0418
AC:
161
ESP6500AA
AF:
0.177
AC:
782
ESP6500EA
AF:
0.0469
AC:
403
ExAC
AF:
0.0680
AC:
8254
Asia WGS
AF:
0.0970
AC:
337
AN:
3478
EpiCase
AF:
0.0462
EpiControl
AF:
0.0466

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Jan 20, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 10, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Merosin deficient congenital muscular dystrophy Benign:1
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

LAMA2-related muscular dystrophy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital muscular dystrophy due to partial LAMA2 deficiency Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.015
.;T;T
Eigen
Benign
-0.030
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.87
D;D;D
MetaRNN
Benign
0.0024
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
.;.;L
PhyloP100
3.1
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.43
.;.;N
REVEL
Benign
0.085
Sift
Benign
0.070
.;.;T
Polyphen
0.018
.;.;B
Vest4
0.18
MPC
0.11
ClinPred
0.011
T
GERP RS
4.7
Varity_R
0.059
gMVP
0.46
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.086
dbscSNV1_RF
Benign
0.29
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306942; hg19: chr6-129635800; COSMIC: COSV70347005; API